HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 18,360
-380 (-2.03%)
Jul 18, 2025, 3:30 PM KST
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 257.82 billion as of July 18, 2025. Its market cap has decreased by -7.51% in one year.
Market Cap
257.82B
Enterprise Value
n/a
Revenue
36.10B
Ranking
n/a
PE Ratio
545.46
Stock Price
18,360.00
Market Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 257.82B, an increase of 205.90%. That is a compound annual growth rate of 12.38%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.16T |
| Celltrion | 39.84T |
| ALTEOGEN | 26.11T |
| Yuhan | 10.15T |
| SK Biopharmaceuticals | 8,074.10B |
| HLB Co., Ltd. | 7,083.28B |
| Peptron | 6,604.80B |
| PharmaResearch | 6,005.22B |